Hims & Hers (HIMS) director Christopher Payne awarded 647 RSUs for Q1 2026 fees

Rhea-AI Filing Summary

Payne Christopher D reported acquisition or exercise transactions in this Form 4 filing.

Hims & Hers Health, Inc. director Christopher D. Payne received a grant of 647 Restricted Stock Units as equity compensation. Each RSU represents a contingent right to receive one share of Class A common stock. The award was issued under the company’s Director Compensation Policy.

The RSUs were granted in lieu of $14,875 in director and committee cash fees for the first quarter of 2026, using a grant price of $22.98. All 647 RSUs will vest in full on the company’s next quarterly vesting date, leaving Payne with 647 RSUs reported as directly owned after this transaction.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Payne Christopher D

Role null

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Unit	647	$0.00	--

Holdings After Transaction: Restricted Stock Unit — 647 shares (Direct, null)

Footnotes (1)

1. The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy, in lieu of the director retainer and committee membership fees for the first quarter of 2026. The number of RSUs granted was calculated by dividing the foregone cash fees of $14,875 by the grant price of $22.98. The RSUs will vest in full on the Company's next quarterly vesting date.

Key Figures

RSUs granted: 647 units Foregone cash fees: $14,875 Grant price: $22.98 per share +2 more

5 metrics

RSUs granted 647 units Restricted Stock Units granted on May 20, 2026

Foregone cash fees $14,875 Director and committee fees for Q1 2026 converted to RSUs

Grant price $22.98 per share Used to calculate RSUs from foregone fees

Underlying shares 647 shares Class A common stock underlying the RSUs

Holdings after transaction 647 RSUs Total RSUs reported as directly owned following grant

Key Terms

Restricted Stock Unit, Director Compensation Policy, grant price, Class A Common Stock

4 terms

Restricted Stock Unit financial

"The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU."

A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.

Director Compensation Policy financial

"The RSUs were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy, in lieu of the director retainer and committee membership fees..."

grant price financial

"The number of RSUs granted was calculated by dividing the foregone cash fees of $14,875 by the grant price of $22.98."

Class A Common Stock financial

"The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU."

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Payne Christopher D

(Last) (First) (Middle)

2269 CHESTNUT STREET, #523

(Street)

SAN FRANCISCO CALIFORNIA 94123

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Hims & Hers Health, Inc. [ HIMS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/20/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	(1)	05/20/2026		A		647		06/15/2026	(2)	Class A Common Stock	647	$0	647	D

Explanation of Responses:

1. The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

2. The RSUs were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy, in lieu of the director retainer and committee membership fees for the first quarter of 2026. The number of RSUs granted was calculated by dividing the foregone cash fees of $14,875 by the grant price of $22.98. The RSUs will vest in full on the Company's next quarterly vesting date.

Remarks:

	/s/ Kimberly Mather, Attorney-in-Fact for Christopher D Payne	05/22/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Hims & Hers Health (HIMS) report for Christopher D. Payne?

Christopher D. Payne received 647 Restricted Stock Units as equity compensation. The RSUs were granted in lieu of director and committee cash fees for the first quarter of 2026 and will vest in full on the company’s next quarterly vesting date.

How many Hims & Hers (HIMS) RSUs did Christopher D. Payne receive and what do they represent?

Payne received 647 Restricted Stock Units from Hims & Hers Health. Each RSU represents a contingent right to receive one share of Class A common stock, meaning he can receive 647 shares if the units fully vest as scheduled.

What cash amount did the Hims & Hers (HIMS) RSU grant replace for Christopher D. Payne?

The RSU grant replaced $14,875 of director and committee cash fees. The company converted those foregone cash fees into 647 Restricted Stock Units using a stated grant price of $22.98 per share for the first quarter of 2026.

How was the number of RSUs for Hims & Hers (HIMS) director Christopher D. Payne calculated?

The 647 RSUs were calculated by dividing $14,875 by $22.98. The filing states that the foregone cash fees of $14,875 were divided by the grant price of $22.98, resulting in a grant of 647 Restricted Stock Units for the director.

When will Christopher D. Payne’s Hims & Hers (HIMS) RSUs vest?

The RSUs will vest in full on the company’s next quarterly vesting date. Once that vesting date occurs, the 647 Restricted Stock Units are scheduled to convert into an equal number of Class A common shares, assuming continued eligibility.

Is the Hims & Hers (HIMS) RSU grant to Christopher D. Payne a market purchase or sale?

The RSU grant is a compensation award, not a market trade. The Form 4 shows a grant coded as an acquisition (A), issued under the Director Compensation Policy in lieu of cash fees, with no open-market buying or selling involved.